BRIEF published on 11/17/2025 at 18:34, 3 months 25 days ago The Vanguard Group's Disclosure on Qualcomm Form 8.3 The Vanguard Group Securities Disclosure Stock Positions Qualcomm
BRIEF published on 11/17/2025 at 18:33, 3 months 25 days ago The Vanguard Group Discloses Position in American Axle & Manufacturing Holdings, Inc. Disclosure The Vanguard Group Takeover Code Common Stock American Axle
BRIEF published on 11/17/2025 at 18:32, 3 months 25 days ago The Vanguard Group Discloses Position in JTC plc Form 8.3 Disclosure Takeover Code Vanguard JTC Plc
BRIEF published on 11/17/2025 at 18:30, 3 months 25 days ago The Vanguard Group Discloses Stake in Avadel Pharmaceuticals Form 8.3 Vanguard Group Shares Disclosure Irish Takeover Avadel Pharmaceuticals
PRESS RELEASE published on 11/17/2025 at 18:29, 3 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.65% interest in Qualcomm Incorporated per Form 8.3 filing. Dealings include purchase and sale of USD 0.0001 common securities Securities Form 8.3 The Vanguard Group Dealings Qualcomm Incorporated
BRIEF published on 11/17/2025 at 18:29, 3 months 25 days ago Vanguard Group Discloses Position in Greencore Group Takeover Code Vanguard Group Share Disclosure Equity Interest Greencore Group
PRESS RELEASE published on 11/17/2025 at 18:28, 3 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses holding 7.47% of American Axle & Manufacturing Holdings, Inc.'s securities in a Form 8.3 filing. Dealings included purchasing 1,691 securities at 6.18 USD per unit Securities Form 8.3 The Vanguard Group Dealings American Axle & Manufacturing Holdings Inc.
BRIEF published on 11/17/2025 at 18:28, 3 months 25 days ago The Vanguard Group Discloses Position in Bluefield Solar Income Fund Form 8.3 The Vanguard Group Takeover Code Financial Disclosure Bluefield Solar
PRESS RELEASE published on 11/17/2025 at 18:27, 3 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.06% interest in JTC plc with Form 8.3 submission. Disclosure includes positions and dealings in relevant securities Securities Form 8.3 Disclosure The Vanguard Group JTC Plc
BRIEF published on 11/17/2025 at 18:26, 3 months 25 days ago The Vanguard Group Discloses Position in Spire Healthcare Form 8.3 Takeover Code Securities Disclosure Vanguard Group Spire Healthcare
Published on 03/13/2026 at 00:30, 19 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
Published on 03/12/2026 at 22:55, 1 hour 54 minutes ago Faraday Copper Reports 2025 Financial Results
Published on 03/12/2026 at 22:15, 2 hours 34 minutes ago Avidian Gold Announces the Appointment of a New Director
Published on 03/12/2026 at 22:00, 2 hours 49 minutes ago Onco-Innovations Announces Closing of Private Placement
Published on 03/12/2026 at 21:30, 3 hours 19 minutes ago Loop Industries to Attend the 38th Annual ROTH Conference, March 22-24, 2026
Published on 03/12/2026 at 23:59, 50 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C - Notice of daily buy back
Published on 03/12/2026 at 21:15, 3 hours 34 minutes ago Amrize Publishes Annual Report for Fiscal Year 2025
Published on 03/12/2026 at 18:45, 6 hours 4 minutes ago Swiss Prime Site: Annual General Meeting approves all proposals of the Board of Directors by a large majority
Published on 03/12/2026 at 18:30, 6 hours 19 minutes ago FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025
Published on 03/12/2026 at 18:00, 6 hours 49 minutes ago NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
Published on 03/12/2026 at 15:06, 9 hours 43 minutes ago FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025
Published on 03/12/2026 at 10:55, 13 hours 54 minutes ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 07:30, 17 hours 19 minutes ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Published on 03/11/2026 at 18:30, 1 day 6 hours ago Filing of the 2025 TF1 Universal Registration Document
